Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis|
Technical and safety concerns still limit the possibility of clinical applications of other promising interventions that are based on the use of human amnion stem cells, embryonic stem cells or induced pluripotent stem cells to replace or regenerate the dysfunctional alveolar epithelium. The authors summarize the current status of the field and identify major challenges and opportunities for the possible future integration of stem cell-based treatments into the currently recommended clinical management strategy for idiopathic pulmonary fibrosis. [Stem Cell Rev]
Visit our reviews page to see a complete list of reviews in the cord blood research field.